i
Mycobacterium Tuberculosis Complex Drug Susceptibility Testing Program: Model Performance Evaluation Program Report of Results August 2017
-
September 2017
-
[PDF-1.30 MB]
Details:
-
Alternative Title:CDC MPEP MTBC DST Report for August 2017
-
Personal Author:
-
Corporate Authors:
-
Description:The Model Performance Evaluation Program (MPEP) is an educational self-assessment tool in which five isolates of M. tuberculosis complex (MTBC) are sent to participating laboratories biannually for staff to monitor their ability to determine drug resistance among the isolates. It is not a formal, graded proficiency testing program. This report includes results for a subset of laboratories performing drug susceptibility tests (DST) for MTBC in the United States. MPEP is a voluntary program, and this report reflects data received from participating laboratory personnel. This aggregate report is prepared in a format that will allow laboratory personnel to compare their DST results with those obtained by other participants using the same methods and drugs, for each isolate. We encourage circulation of this report to personnel who are either involved with DST or reporting and interpreting results for MTBC isolates.
The purpose of this report is to present results of the U.S. Centers for Disease Control and Prevention (CDC) Model Performance Evaluation Program (MPEP) for Mycobacterium tuberculosis complex (MTBC) drug susceptibility testing survey sent to participants in August 2017.
The findings and conclusions in this report are those of the author(s) and do not necessarily represent the views of the Centers for Disease Control and Prevention.
Running title: CDC MPEP MTBC DST Report for August 2017
CS 289706-A
MPEP-August-2017-FinalReport.pdf
-
Subjects:
-
Series:
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
